JPRN-jRCTs021180022招募中2 期
A Phase 2 Trial of Multimodal Treatment based on VDC-IE with Interval Compressed Schedule by using G-CSF for Patients with Non-metastatic Ewing Sarcoma Family Tumor - JESS14
Sano Hideki0 个研究点目标入组 66 人开始时间: 2019年3月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 < 50age old（—）
- 性别
- All
入选标准
- •1. Histologically confirmed newly diagnosed ESFT.
- •2. Localized tumor.
- •3. Within 3 weeks after histologically diagnosis.
- •4. No history of prior chemotherapy or radiation therapy.
- •5. Age younger than 50 years old.
- •6. Patients must have sufficient organ function satisfying the labolatory data
- •listed below.
- •7. All patients and/or their parents or legal guardians must sign a written
- •informed consent.
- •8. Remain evaluable lesion.(Not complete resection)
- •9. Completion of primary registration for pediatric solid tumor database.
排除标准
- •1. Patients with synchronous or metachronous concomitant malignancies.
- •2. Patients who are pregnant or breast feeding mother.
- •3. Patients with mental disorder who is considered inappropriate for study
- •participation.
- •4. Patients with heart disease which required any therapy.
- •5. Patients with active infection which required any therapy.
- •6. Patients with any other inappropriate condition for study participation judged
- •by physician.
- •7. HBs antigen positive. HBs antigen negative but HBc antibody or HBs
- •antibody positive. ( exclude HBs antibody positive due to HBV vaccination)
- •8. Patients who had continuous steroid therapy.
研究者
相似试验
招募中
2 期
A Phase 2 Trial of Multimodal Treatment based on VDC-IE with Interval Compressed Schedule by using G-CSF for Patients with Non-metastatic Ewing Sarcoma Family Tumoron-metastatic Ewing Sarcoma Family TumorJPRN-UMIN000020903Japan Ewing Sarcoma Study Group66
已完成
2 期
A phase II study of multimodality therapy with introduction chemoradiotherapy before surgery in patients with pathological mediastinal lymph node metastasis (N2 Stage IIIA) non -small cell lung canceron-small cell lung cancerJPRN-UMIN000029435Department of respiratory medicine, Kurashiki Central Hospital20
招募中
不适用
Pilot study of multimodality treatment based on a new risk stratification in patients with medulloblastomaJPRN-UMIN000014488Japanese Pediatric Brain Tumor Consortium30
进行中（未招募）
不适用
A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.SQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395EUCTR2005-001132-72-ITISTITUTO EUROPEO DI ONCOLOGIA42
进行中（未招募）
2 期
WJOG11118JPRN-jRCTs041200046Hirotsugu Kenmotsu30